PLSE Stock Summary and Trading Ideas (Pulse Biosciences | NASDAQ:PLSE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Pulse Biosciences trades on the NASDAQ stock market under the symbol PLSE.

As of April 26, 2024, PLSE stock price climbed to $7.19 with 70,449 million shares trading.

PLSE has a beta of 1.02, meaning it tends to be more sensitive to market movements. PLSE has a correlation of 0.02 to the broad based SPY ETF.

PLSE has a market cap of $397.07 million. This is considered a Small Cap stock.

In the last 3 years, PLSE stock traded as high as $29.16 and as low as $1.18.

The top ETF exchange traded funds that PLSE belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

PLSE has underperformed the market in the last year with a return of +23.3%, while the SPY ETF gained +27.4%. In the last 3 month period, PLSE fell short of the market, returning -15.6%, while SPY returned +4.6%. However, in the most recent 2 weeks PLSE has outperformed the stock market by returning -0.4%, while SPY returned -0.5%.

PLSE support price is $6.33 and resistance is $7.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSE stock will trade within this expected range on the day.